Suede may be considered a cold-weather staple, but Johnson is proving that it's far too good to pack away for the season.
And then, rising up another hill, we saw it, almost appearing out of nowhere: An expansive piece of property with swaying palm trees, 200 sweet-smelling garden beds, and thatched-roofed cottages scattered along the outer edges.“It's a little oasis in the jungle,” said Ben Simmons, founder of The Farm.
Simmons, who also runs Harbour Island’s, actually built the farm part of The Farm back in 2018. It provided fruits and vegetables and eggs (there are about 70 clucking chickens on-site) to the kitchens of his two hotels and his wedding business. But Simmons—who acquired the land in a squabble that dates back to a dramatic 18th-century sea battle involving his Eleutheran ancestors defeating the much more powerful Spaniards—had bigger plans for his agricultural oasis. He wanted to grow his business, he wanted to increase the number of Bahamian-owned properties in the Caribbean, and, most importantly, he wanted to instill in travelers and locals the ideas of sustainability and living off the Caribbean’s rich, fertile land.So, five years later, he thought, why not also build another hotel
The Farm opened in November 2024 as part of Simmons’chain. His team envisions it being a place for visitors to stay, but also to learn about gardening and growing. He hopes to arrange speakers and seminars during the low seasons. He also plans to expand the gardens, the diversity of crops, and the number of chickens.
Celebrities like Michael Jordan, Derek Jeter, and Eli Manning have already found their way to The Farm’s exceptional Sunday Brunch. Kendall Jenner’s assistant recently got married next door at The Other Side.
Still, even with all that fanfare, when you’re here, it’s like nobody else is around. All I heard were the bees humming inside the flowers, someone slipping quietly into the pool, and the whoosh of a welcome breeze finding its way from the nearby Atlantic.works in animals and, eventually, in human trials. Researchers also hope to design new drugs that copy mefloquine’s effects but with even fewer side effects or better targeting.
This discovery is not just about adding another drug to a treatment plan. It’s about understandingthe drugs work at a deep, molecular level. Knowing exactly where and how mefloquine binds to the ribosome gives scientists a map. That map can be used to design better therapies—ones that deliver the same benefits with more precision and less harm.
https://youtube.com/shorts/HPeZ-3NWR6k?feature=shareThe research also suggests a broader principle: read-through of premature stop codons isn’t just about tricking the ribosome. It involves shifting its internal dynamics—how it moves, rotates, and interprets genetic instructions. By targeting those dynamics, scientists can potentially create more effective treatments not just for DMD, but for a host of